Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Oral edaravone demonstrated a favorable safety profile in patients with amyotrophic lateral sclerosis after 48 weeks of treatment
PaperCitations, authors & open-access status
Oral edaravone demonstrated a favorable safety profile in patients with amyotrophic lateral sclerosis after 48 weeks of treatment is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 27 citations, 2022 year and hybrid oa status.
27
Citations
2022
Year
hybrid
OA Status